Estrogen protection in Friedreich's ataxia skin fibroblasts

Endocrinology

Volumn 152, Issue 7, 2011, Pages 2742-2749

  Richardson, Timothy E ^a   Yang, Shao Hua ^a   Wen, Yi ^a   Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; PHENOL; REACTIVE OXYGEN METABOLITE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; FRIEDREICH ATAXIA; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN FIBROBLAST;

ADULT; ANTIOXIDANTS; BUTHIONINE SULFOXIMINE; CELL SURVIVAL; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FIBROBLASTS; FRIEDREICH ATAXIA; GLUTATHIONE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHENOLS; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED; SKIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79959404165     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2011-0184     Document Type: Article

References (46)

1. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AH 2000 Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9:275-282 (Pubitemid 30052751)
2. Leone M, Brignolio F, Rosso MG, Curtoni ES, Moroni A, Tribolo A, Schiffer D 1990 Friedreich's ataxia: a descriptive epidemiological study in an Italian population. Clin Genet 38:161-169 (Pubitemid 20269269)
3. Pandolfo M 1998 Molecular genetics and pathogenesis of Friedreich ataxia. Neuromuscul Disord 8:409-415 (Pubitemid 28388942)
4. Schulz JB, Boesch S, Bürk K, Dürr A, Giunti P, Mariotti C, Pousset F, Schöls L, Vankan P, Pandolfo M 2009 Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol 5:222-234
5. Harding AE 1983 Classification of the hereditary ataxias and paraplegias. Lancet 1:1151-1155 (Pubitemid 13084682)
6. Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocazza S, Koenig M, Pandolfo M 1996 Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427
7. Isnard R, Kalotka H, Dürr A, Cossée M, Schmitt M, Pousset F, Thomas D, Brice A, Koenig M, Komajda M 1997 Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia. Circulation 95:2247-2249
8. Lodi R, Tonon C, Calabrese V, Schapira AH 2006 Friedreich's ataxia: from disease mechanisms to therapeutic interventions. Antioxid Redox Signal 8:438-443 (Pubitemid 43741314)
9. Montermini L, Andermann E, Labuda M, Richter A, Pandolfo M, Cavalcanti F, Pianese L, Iodice L, Farina G, Monticelli A, Turano M, Filla A, De Michele G, Cocozza S 1997 The Friedreich ataxia GAA triplet repeat: permutation and normal alleles. Hum Mol Genet 6:1261-1266 (Pubitemid 27351065)
10. Al-Mahdawi S, Pinto RM, Varshney D, Lawrence L, Lowrie MB, Hughes S, Webster Z, Blake J, Cooper JM, King R, Pook MA 2006 GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics 88:580-590 (Pubitemid 44540244)
11. Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J 1997 Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276:1709-1712 (Pubitemid 27421980)
12. Jauslin ML, Meier T, Smith RA, Murphy MP 2003 Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 17:1972-1974
13. Jauslin ML, Wirth T, Meier T, Shoumacher F 2002 A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet 11:3055-3063 (Pubitemid 35414819)
14. Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P 1997 Aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia. Nat Genet 17:215-217
15. Gibson GE, Sheu KF, Blass JP 1998 Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105:855-870 (Pubitemid 28539834)
16. Lenaz G, Baracca A, Barbero G, Bergamini C, Dalmonte ME, Del Sole M, Faccioli M, Falasca A, Fato R, Genova ML, Sgarbi G, Solaini G 2010 Mitochondrial respiratory chain super-complex I-III in physiology and pathology. Biochim Biophys Acta 1797:633-640
17. Lenaz G, Baracca A, Fato R, Genova ML, Solaini G 2006 Mitochondrial complex I: structure, function, and implications in neurodegeneration. Ital J Biochem 55:232-253
18. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y 1989 Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163:1450-1455 (Pubitemid 19244751)
19. Parker Jr WD, Boyson SJ, Parks JK 1989 Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26:719-723 (Pubitemid 20011004)
20. Simpkins JW, Dykens JA 2008 Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev 57:421-430 (Pubitemid 351381759)
21. Dürr A, Cossée M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel JL, Brice A, Koenig M 1996 Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335: 1169-1175
22. Geoffroy G, Barbeau A, Breton G, Lemieux B, Aube M, Leger C, Bouchard JP 1976 Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can J Neurol Sci 3:279-286 (Pubitemid 8067178)
23. Dutka DP, Donnelly JE, Palka P, Lange A, Nuñez DJ, Nihoyannopoulous P 2000 Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients. Circulation 102:1276-1282
24. Harding AE 1981 Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104:589-620 (Pubitemid 12202197)
25. Bishop J, Simpkins JW 1994 Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci 5:303-308 (Pubitemid 24264569)
26. Behl C, Widmann M, Trapp T, Holsboer F 1995 17-β estradiol protects neurons from oxidative stress induced cell death in vitro. Biochem Biophys Res Commun 216:473-482
27. Goodman Y, Bruce AJ, Cheng B, Mattson MP 1996 Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844 (Pubitemid 26118770)
28. Singer CA, Rogers KL, Strickland TM, Dorsa DM 1996 Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 212:13-16 (Pubitemid 26267070)
29. Simpkins JW, Yang SH, Sarkar SN, Pearce V 2008 Estrogen actions on mitochondria-physiological and pathological implications. Mol Cell Endocrinol 290:51-59
30. Simpkins JW, Yi KD, Yang SH 2009 Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens. Front Neuroendocrinol 30:93-105
31. Perez E, Cai ZY, Covey DF, Simpkins JW 2006 Neuroprotective effects of estratriene analogs: structure-activity relationships and molecular optimization. Drug Dev Res 66:78-92
32. Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Perez EJ, Liu R, Simpkins JW 2003 Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci USA 100:11741-11746 (Pubitemid 37206005)
33. Prokai-Tatrai K, Perjesi P, Rivera-Portalatin NM, Simpkins JW, Prokai L 2008 Mechanistic investigation on the antioxidant action of a neuroprotective estrogen derivative. Steroids 73:280-288 (Pubitemid 351174167)
34. WangJ, Green PS, Simpkins JW 2001 Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem 77:804-811 (Pubitemid 32466777)
35. Wang X, Simpkins JW, Dykens JA, Cammarata PR 2003 Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest Ophthalmol Vis Sci 44:2067-2075 (Pubitemid 36520301)
36. 2+ channels. Proc Natl Acad Sci USA 105:15148-15153
37. Jayachandran M, Preston CC, Hunter LW, Jahangir A, Owen WG, Korach KS, Miller VM 2010 Loss of estrogen receptor β decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice. Age (Dordr) 32:109-121
38. Dykens JA, Moos WH, Howell N 2005 Development of 17α-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study. Ann NY Acad Sci 1052:116-135 (Pubitemid 41338962)
39. Yi KD, Cai ZY, Covey DF, Simpkins JW 2008 Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation. J Pharmacol Exp Ther 324:1188-1195 (Pubitemid 351397839)
40. de Cupis A, Noonan D, Pirani P, Ferrera A, Clerico L, Favoni RE 1995 Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells. Br J Pharmacol 116:2391-2400
41. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greeenwald D, Yu CJ, Bodor N, Day AL 1997 Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87:724-730 (Pubitemid 27454591)
42. Haczynski J, Tarkowski R, Jarzabek K, Slomczynska M, Wolczynski S, Magoffin DA, Jakowiki JA, Jakimiuk AJ 2002 Human cultured skin fibroblasts express estrogen receptor α and β. Int J Mol Med 10:149-153
43. Madeo A, Maggiolini M 2010 Nuclear alternate estrogen receptor GPR30 mediates 17β-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 70:6036-6046
44. Jauslin ML, Vertuani S, Durini E, Buzzoni L, Ciliberti N, Verdecchia S, Palozza P, Meier T, Manfredini S 2007 Protective effects of Fe- Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich ataxia. Mol Cell Biochem 302: 79-85 (Pubitemid 47202323)
45. Li K, Besse EK, Ha D, Kovtunovych G, Rouault TA 2008 Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum Mol Genet 17:2265-2273
46. Ku S, Soragni E, Campau E, Thomas EA, Altun G, Laurent LC, Loring JF, Napierala M, Gottesfeld JM 2010 Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA-TTC triplet repeat instability. Cell Stem Cell 7:631-637